|
|
|
|
|
|
Actinium Pharmaceuticals Inc (ATNM)
|
|
0.9528 +0.0228 (+2.4516%)
|
7/27/2017 2:35pm
|
|
Open:
|
0.9400
|
Pre. Close:
|
0.9300
|
|
High:
|
0.9800
|
Low:
|
0.9400
|
|
Volume:
|
176,991
|
Market Cap:
|
55.69M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
0.96 - 0.99
|
0.99 - 1.02
|
|
Low:
|
0.88 - 0.89
|
0.89 - 0.9
|
|
Close:
|
0.9 - 0.93
|
0.93 - 0.96
|
|
|
|
|
|
|
Technical analysis (as of: 2017-07-27 2:05:35 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.
|
|
Target:
|
Six months: 1.36 One year: 1.56
|
|
Support:
|
Support1: 0.90 Support2: 0.75
|
|
Resistance:
|
Resistance1:
1.17 Resistance2: 1.33
|
|
Pivot:
|
1.01 
|
|
Moving Averages:
|
MA(5): 0.96 MA(20): 1.05
MA(100): 1.34 MA(250): 1.30
|
|
MACD:
|
MACD(12,26):
-0.08 Signal(12,26,9): -0.07
|
|
%K %D:
|
%K(14,3): 15.23 %D(3): 16.73
|
|
RSI:
|
RSI(14): 31.59
|
|
52-Week:
|
High: 2.1500
Low: 0.8600 Change(%): -46.6
|
|
Average Vol(K):
|
3-Month: 36486
10-Days 14200
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.ATNM has closed above bottom band by 16.9%. Bollinger Bands are 29.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
Fri, 09 Jun 2017 11:34:26 GMT
Actinium Pharmaceuticals Announces Appointment of Sandesh Seth as Chief ...
Mon, 19 Dec 2016 12:02:11 GMT
Actinium Pharmaceuticals Appoints Jeannine Larrieux, Ph.D. as Director of ...
Thu, 08 Jun 2017 11:31:45 GMT
Actinium Pharmaceuticals Highlights Presence at Upcoming Society of Nuclear ...
Fri, 10 Feb 2017 18:22:30 GMT
Actinium Pharmaceuticals (ATNM) has Considerable Potential in 2017
Thu, 13 Jul 2017 10:52:30 GMT
Actinium Pharmaceuticals to Host Webinar Focused on Actimab-A and Recent ...
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
